What treatment considerations do you make for elderly patients with relapsed/refractory follicular lymphoma?
Are you more inclined to use non cytotoxic regimens such as R2 or PI3K inhibitors?
Community PollStarted
Which of the following regimens are you generally comfortable using for elderly patients with R/R FL and average age-related comorbidities?
51 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Medical Oncology · City of Hope
Answered on
Treatment options for R/R FL patients depend not only on the condition of the patient but what was received in 1st line and the duration of that line of therapy. Given that if a patient has received chemo-immunotherapy in the frontline setting and had a prolonged remission (> 5 years), then these ag...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Medical Oncology · Rutgers Cancer Institute of New Jersey
Answered on
Taking age into consideration is of course, important and relevant, but it is not the only or even, oftentimes, the key determinant in treatment decision-making in follicular lymphoma. Age, performance status, comorbidities, mobility, independence (both ADLs as well as travel/transit), patient prefe...
Join for free or sign in to see the full answer